| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/21/2000 | EP1009764A1 VACCINE COMPOSITIONS COMPRISING THE $i(HELICOBACTER PYLORI) FlgE POLYPEPTIDE |
| 06/21/2000 | EP1009763A1 Synthetic hepatitis c genes |
| 06/21/2000 | EP1009761A1 Biomolecules comprising an elastomeric peptide |
| 06/21/2000 | EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 06/21/2000 | EP1009759A1 Carbohydrate crosslinked glycoprotein crystals |
| 06/21/2000 | EP1009753A1 Hypoxia-regulated genes |
| 06/21/2000 | EP1009443A1 priA POLYPEPTIDES |
| 06/21/2000 | EP1009442A1 Improvements in or relating to regulation of t cell activation |
| 06/21/2000 | EP1009434A1 Stabilizers containing recombinant human serum albumin for live virus vaccines |
| 06/21/2000 | EP1009433A1 Therapeutic composition and method of treatment |
| 06/21/2000 | EP1009432A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses |
| 06/21/2000 | EP1009431A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies |
| 06/21/2000 | EP1009430A1 Vaccines |
| 06/21/2000 | EP1009429A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| 06/21/2000 | EP1009428A1 Vaginal suppository vaccine for urogenital infections |
| 06/21/2000 | EP1009426A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 06/21/2000 | EP1009421A1 Methods and compositions for enhanced wound healing |
| 06/21/2000 | EP1009419A2 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 06/21/2000 | EP1009413A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 06/21/2000 | EP1009386A1 Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof |
| 06/21/2000 | EP1009382A1 Oil in water emulsions containing saponins |
| 06/21/2000 | EP1009232A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 06/21/2000 | EP0825875B1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 06/21/2000 | EP0820304B1 Chlamydia vaccines |
| 06/21/2000 | CN1053699C Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/21/2000 | CN1053590C Frozen dried heptitis A toxicity-reduced biovaccine and protective agent thereof |
| 06/20/2000 | US6077950 Adjusting efficiency of animals antibody response by administering animal a polypeptide to activate antibody response |
| 06/20/2000 | US6077935 Unglycosylated viral polypeptide; for the detection of viral antigens in human blood; for vaccine development |
| 06/20/2000 | US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell |
| 06/20/2000 | US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 06/20/2000 | US6077691 Infecting mammalian kidney cell with chimeric vaccina virus with synthetic promoter linked to sequence that encodes pres1-pres2-s hepatitis antigen, culturing and lysing the infected cell, harvesting antigen |
| 06/20/2000 | US6077690 Dna which encodes a 54 kilodalton protein of specific amino acid sequence; for vaccines, diagnosis of infections, and recombinant production of protein |
| 06/20/2000 | US6077687 Flea aminopeptidase nucleic acid molecules and uses thereof |
| 06/20/2000 | US6077685 Tumor suppressor merlin and antibodies thereof |
| 06/20/2000 | US6077677 Amino acid sequence; bactericides; prophylactic agents; diagnosis; drug screening |
| 06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 06/20/2000 | US6077662 Virus-like particles, methods and immunogenic compositions |
| 06/20/2000 | US6077519 Antitumor vaccine comprising t-cell epitopes recovered through acid elution from patient's viable resected tumor tissue and as adjuvant dendritic cells and/or cytokines |
| 06/20/2000 | US6077518 Cloning of mite allergens |
| 06/20/2000 | US6077517 House dust mite allergen, Der p VII, and uses thereof |
| 06/20/2000 | US6077516 Live vaccine against colibacillosis |
| 06/20/2000 | US6077515 Vaccine comprising whole cells from a purified culture of flagella-less b. burgdorderi having phenotypic characteristics of atcc no. 55131 and a carrier |
| 06/20/2000 | US6077514 Characterized in that the viruses have a codon encoding an amino acid in the f protein chosen from specified amino acids at their amino acid numbers; temperature sensitive rsv phenotype; immunizing |
| 06/20/2000 | US6077511 Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection |
| 06/20/2000 | US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 06/20/2000 | US6077509 Given amino acid sequences that are immunodominant in humans suffering from multiple sclerosis |
| 06/20/2000 | US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent |
| 06/20/2000 | CA2028804C Biomosaic polymers and method for preparing same |
| 06/20/2000 | CA2026505C Therapeutical elements for the oral administration of a medicament to animals and process for their preparation |
| 06/20/2000 | CA2000479C Vasopermeability-enhancing conjugates |
| 06/20/2000 | CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp |
| 06/15/2000 | WO2000034780A2 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 06/15/2000 | WO2000034499A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/15/2000 | WO2000034498A1 Two-step immunization procedure against chlamydia infection |
| 06/15/2000 | WO2000034497A2 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors |
| 06/15/2000 | WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | WO2000034487A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 06/15/2000 | WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | WO2000034482A2 Novel compounds derived from neisseria meningitidis |
| 06/15/2000 | WO2000034480A1 Polypeptides and polynucleotides 'basb040' from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 06/15/2000 | WO2000034474A2 Growth factor homolog zvegf3 |
| 06/15/2000 | WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | WO2000034467A1 Cancer cell vaccine |
| 06/15/2000 | WO2000034465A2 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS) |
| 06/15/2000 | WO2000034459A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/15/2000 | WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 06/15/2000 | WO2000034445A2 Live attenuated venezuelan equine encephalitis vaccine |
| 06/15/2000 | WO2000034444A2 Method and composition for preserving viruses |
| 06/15/2000 | WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 06/15/2000 | WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor |
| 06/15/2000 | WO2000034308A2 Protein transduction system and methods of use thereof |
| 06/15/2000 | WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1') |
| 06/15/2000 | WO2000033874A2 Boron neutron capture therapy using pre-targeting methods |
| 06/15/2000 | WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen |
| 06/15/2000 | WO2000033871A2 Use of human prostate tumour cell lines in cancer treatment |
| 06/15/2000 | WO2000033870A2 New cancer treatments |
| 06/15/2000 | WO2000033869A2 Use of human prostrate cell lines in cancer treatment |
| 06/15/2000 | WO2000033861A2 Pharmaceutical compositions containing protein-disulfide isomerases |
| 06/15/2000 | WO2000033659A1 Compositions for treating alzheimer's disease and other amyloidoses |
| 06/15/2000 | WO2000012678A3 Staphylococcus aureus genes and polypeptides |
| 06/15/2000 | WO2000010600A3 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents |
| 06/15/2000 | WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 06/15/2000 | WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 06/15/2000 | WO2000006196A3 Multivalent human-bovine rotavirus vaccine |
| 06/15/2000 | WO2000005378A3 Streptococcus suis vaccines and diagnostic tests |
| 06/15/2000 | WO2000005253A3 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 06/15/2000 | WO2000003731A3 Vaccine to prevent and treat chlamydial infections |
| 06/15/2000 | WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 06/15/2000 | WO1999061056A9 Methods and products for inducing mucosal immunity |
| 06/15/2000 | WO1999061052A9 Oral immunization with papillomavirus virus-like particles |
| 06/15/2000 | WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 06/15/2000 | WO1999029724A3 Dna encoding pasteurella multocida outer membrane protein |
| 06/15/2000 | WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2000 | WO1999002550A8 Ctl epitopes from ebv |
| 06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | CA2354644A1 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1") |
| 06/15/2000 | CA2354374A1 Live attenuated venezuelan equine encephalitis vaccine |
| 06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |